Abstract:Key PointsAlthough for a long time necrosis was considered to be a purely accidental cell death subroutine, multiple lines of evidence now show that necrotic cell death can be regulated, both in its occurrence and in its course. The term 'necroptosis' was introduced by Yuan's research group in 2005 to indicate 'programmed' (as opposed to 'accidental') necrosis.The best characterized signal transduction cascade leading to necroptosis is initiated by ligand-bound tumour necrosis factor (TNF) receptor 1 (TNFR1), which allows for the assembly of a cytoplasmic supramolecular complex — TNFR complex I — that includes (among other proteins) TNFR-associated death domain (TRADD), cellular inhibitor of apoptosis 1 (cIAP1), cIAP2 and receptor-interacting protein kinase 1 (RIP1; also known as RIPK1).In complex I, RIP1 can be ubiquitylated by cIAPs and deubiquitylated by cylindromatosis (CYLD) and A20 (also known as TNFAIP3). Whereas ubiquitylated RIP1 promotes the activation of the nuclear factor κB (NF-κB) system, deubiquitylated RIP1 functions as a cell death-inducing kinase.On TNFR1 internalization, the so-called TNFR complex II is formed, which contains TRADD, FAS-associated protein with a death domain (FADD) and caspase 8. Normally, caspase 8 becomes activated in complex II, thereby igniting a pro-apoptotic caspase cascade. When caspase activation is prevented, however, RIP1 physically and functionally interacts with RIP3 (also known as RIPK3), thereby generating a necroptosis-inducing complex known as the necrosome.Necroptosis can also be ignited by pathogen recognition receptors, including Toll-like receptors, NOD-like receptors and retinoic acid-inducible gene I-like receptors, as well as in response to DNA damage, presumably by a poly(ADP-ribose) polymerase-1 (PARP1)-dependent signalling pathway.Although the underlying molecular mechanisms remain obscure, reactive oxygen species (ROS), bioenergetic metabolic cascades and the release of cytotoxic factors from lysosomes and mitochondria all contribute to the execution of necroptosis.Regulated necrosis has been seen in multiple, evolutionarily distant model organisms, including yeast, nematodes, fruit flies, rodents, primates and human cells, corroborating the notion that necroptosis may represent a phylogenetically conserved mechanism for programmed cell death.Numerous in vivo studies indicate that the inhibition of necroptosis (by genetic means or by RIP1-targeting agents called necrostatins) can confer consistent cytoprotection, suggesting that necroptosis may constitute a promising target for drug development.

Research progress in necroptosis

Necroptosis in Inflammatory Bowel Disease and Other Intestinal Diseases

Necroptosis: an emerging form of programmed cell death.

Necroptosis and its role in infectious diseases

Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target

Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.

[Research Progress on Receptor Interacting Proteins in Inflammation].

Necroptosis inhibitors: mechanisms of action and therapeutic potential

Necroptosis in health and diseases

Molecular mechanisms of necroptosis: an ordered cellular explosion

Mitochondrial Mechanisms of Necroptosis in Liver Diseases

Recognition of necroptosis: From molecular mechanisms to detection methods

Necroptosis: a regulated inflammatory mode of cell death

Necroptosis: Mechanisms and Relevance to Disease.

Necroptosis in bacterial infections

The Potential Role of Necroptosis in Clinical Diseases (Review)

Knowledge Mapping of Necroptosis From 2012 to 2021: A Bibliometric Analysis

Regulated necrosis, a proinflammatory cell death, potentially counteracts pathogenic infections

A narrative review of the role of necroptosis in liver disease: a double-edged sword

Necroptosis in apical periodontitis: A programmed cell death with multiple roles

Mediators of necroptosis: from cell death to metabolic regulation